GITNUXSOFTWARE REVIEW
Top 9 Best Toxicity Prediction Software of 2026
Compare toxicity prediction software tools and use cases, including VEGA, SwissADME, and OECD QSAR Toolbox, for chemistry research shortlists.
How we ranked these tools
Vendors set the topic, but our editors set the inclusion criteria and the evaluation framework before research starts.
Search agents gather the source set and the review record, including transcriptions of video reviews and podcasts.
Framework: Features 40% · Ease 30% · Value 30%
Gitnux may earn a commission through links on this page. This does not influence our reviews. Editorial policy
VEGA is the best pick for chemists who need repeatable batch toxicity predictions across multiple endpoints because its endpoint-focused batch runs keep output structure consistent for direct comparisons across molecules, whereas SwissADME fits teams doing fast SMILES-based early safety triage since it bundles medicinal-chemistry and absorption-distribution style panels into one structured report.
Editor’s top 3 picks
Three quick recommendations before you dive into the full comparison below — each one leads on a different dimension.
VEGA
Endpoint-focused batch runs that keep output structure consistent across predictions for the same input batch.
Best for: Fits when chemists need repeatable batch toxicity predictions across multiple endpoints with minimal session-level tuning.
SwissADME
Editor pickSingle-input reports combine absorption, distribution, and medicinal-chemistry property panels in one structured output.
Best for: Fits when teams need fast SMILES-based ADMET triage and medicinal-chemistry filters without building QSAR pipelines.
OECD QSAR Toolbox
Editor pickApplicability domain and read-across analysis are built into the model workspace workflow, not added as external scripts.
Best for: Fits when teams need structured QSAR model workspaces with read-across and applicability domain checks.
Comparison Table
VEGA
vertical specialistFree platform for QSAR-based toxicity prediction across multiple environmental and human health endpoints.
Endpoint-focused batch runs that keep output structure consistent across predictions for the same input batch.
VEGA is a toxicity prediction workflow accessed through vegahub.eu, with batch-oriented inference aimed at chemists who need repeated endpoint runs. The tool supports common QSAR style inputs such as SMILES and structure files, then produces endpoint-specific predictions like mutagenicity and organ toxicity.
VEGA’s distinct strength is a workflow focus that emphasizes running many structures through the same modeling configuration and collecting comparable outputs across endpoints. Automation is centered on repeatability rather than interactive exploration, which supports high-throughput screening and downstream read-across style comparison.
- +Batch structure processing for repeated endpoint runs on large input sets
- +Endpoint outputs are organized for direct comparison across molecules
- +Accepts common chemistry file inputs that reduce preprocessing effort
- +Workflow-first design supports repeatable screening runs
- –Limited evidence of configurable model selection for each endpoint
- –Less guidance for applicability domain reporting in predictions
- –Batch runs reduce interactive tuning during a session
- –Integration details around API access are not clearly surfaced
medicinal chemists
Run endpoint predictions on screening series
Consistent hazard triage across analogs
high-throughput screening teams
Collect mutagenicity and organ toxicity
Reduced manual QC effort
Show 1 more scenario
computational toxicity analysts
Repeat runs for configuration auditing
More defensible prediction records
Analysts rerun many compounds under identical workflow settings to check endpoint reproducibility.
Best for: Fits when chemists need repeatable batch toxicity predictions across multiple endpoints with minimal session-level tuning.
SwissADME
SMBSwissADME calculates medicinal chemistry and ADME properties and includes some liability-related alerts relevant to early safety screening.
Single-input reports combine absorption, distribution, and medicinal-chemistry property panels in one structured output.
SwissADME converts SMILES-based inputs into a packed set of absorption, distribution, and medicinal chemistry–oriented readouts that chemists can interpret without building a modeling workflow. It reports physicochemical filters and common ADMET-related endpoint predictions like GI absorption and brain penetration alongside structure-derived medicinal chemistry metrics.
The tool’s output is organized for quick triage rather than automated endpoint generation across many endpoints in one API call. SwissADME also supports batch-style use through file-based input to reduce manual SMILES entry when screening series.
- +SMILES-to-readouts workflow supports rapid ADMET-style triage
- +Medicinal chemistry metrics sit beside absorption and distribution predictions
- +Batch input reduces manual effort for structure series
- +Results are presented in a structured, human-readable summary
- –Toxicity coverage is narrower than end-to-end in silico toxicity modeling suites
- –No explicit batch prediction API surface for automated pipeline integration
medicinal chemistry teams
Triage ADMET from SMILES lists
Faster compound selection
lead optimization groups
Screen GI absorption and brain penetration
Clearer early-stage prioritization
Show 1 more scenario
research assistants
Upload batch SMILES files
Less transcription overhead
Users reduce manual SMILES entry by providing structure files for series-level runs.
Best for: Fits when teams need fast SMILES-based ADMET triage and medicinal-chemistry filters without building QSAR pipelines.
OECD QSAR Toolbox
vertical specialistSoftware application for grouping chemicals, read-across, and hazard prediction including toxicity endpoints.
Applicability domain and read-across analysis are built into the model workspace workflow, not added as external scripts.
OECD QSAR Toolbox runs QSAR model workspaces for chemical structure processing, endpoint annotation, and prediction workflows on in silico toxicity endpoints. Its core differentiators are model and dataset management for read-across, applicability domain assessment, and support for structured evidence linking to modeling results.
Batch prediction is handled through the Toolbox workflow rather than a general-purpose analytics stack. Export and report-style output support review-centric documentation of model inputs and results.
- +Read-across workflow ties chemical similarity to endpoint evidence
- +Applicability domain tooling supports defensible applicability statements
- +Model workspace captures inputs, transformations, and prediction context
- +Import and export formats support SMILES and common structure files
- –Automation and API surface for batch scoring is limited
- –Model setup and curation require careful manual configuration
- –Workflow depth varies by endpoint and model availability
- –Enterprise governance features like audit logs are not a primary focus
regulatory modelers
Manage model and dataset workspaces
Better traceability for reports
risk assessment teams
Assess applicability domain before prediction
Fewer unreliable extrapolations
Show 1 more scenario
computational chemists
Run structured read-across workflows
More defensible endpoint support
Users pair endpoint annotation with read-across oriented workflows rather than generic analytics.
Best for: Fits when teams need structured QSAR model workspaces with read-across and applicability domain checks.
TIMES
vertical specialistTIMES predicts metabolic transformation, biodegradation, and toxicity outcomes from chemical structure and simulators.
Mechanism-based metabolism simulation links chemical transformations to toxicity predictions instead of relying only on parent-compound similarity.
TIMES builds predicted metabolic pathways before evaluating toxicity, which can expose risks created by metabolites rather than only the parent compound. Endpoint modules support QSAR modeling for several regulatory and research questions, including genotoxicity and organ-specific toxicity assessment. The mechanistic workflow gives toxicologists more context than a single classification score.
- +Simulates metabolite formation before toxicity assessment
- +Provides endpoint-specific mechanistic explanations
- +Covers multiple regulatory toxicity endpoints
- +Includes applicability-domain and alert information
- –Requires toxicology expertise for pathway interpretation
- –Endpoint modules use separate model workflows
- –Public API and batch automation are not clearly documented
- –Predictions weaken for chemicals outside model domains
Medicinal chemistry teams
Prioritize compounds before safety assays
Fewer high-risk compounds advance
Regulatory toxicologists
Support endpoint assessment dossiers
More explainable screening evidence
Show 2 more scenarios
Environmental risk assessors
Screen aquatic toxicity concerns
Prioritized aquatic testing
Acute aquatic toxicity models help rank substances for follow-up testing and environmental review.
Industrial chemical researchers
Compare candidate substances
Earlier candidate elimination
Metabolism pathways and toxicity predictions support read-across decisions between related chemicals.
Best for: Fits when toxicologists need metabolism-aware screening across several toxicity endpoints before laboratory testing.
Toxtree
vertical specialistRule-based software for toxic hazard estimation using decision tree approaches and structural alerts.
Interactive highlighting of which substructures triggered specific toxicity alerts.
Toxtree supports end users who need fast, structure-driven hazard triage inside a review workflow. It can ingest SMILES and parse SDF and MOL inputs to run built-in alert rules and produce reportable results for chemists and safety reviewers. The workflow design favors inspection of which structural features triggered alerts and what those alerts imply for follow-up.
- +Rule-based structural alerts with clear, inspectable triggers
- +Local desktop workflow that avoids network dependency during runs
- +Accepts SMILES and SDF inputs for common structure handoffs
- +Report views organize results for rapid screening review
- –Alert coverage does not replace dedicated QSAR endpoint models
- –Advanced automation and API-based batch execution are limited
Medicinal chemistry teams
Triage lead series for obvious hazard alerts
Faster selection of low-risk series
Regulatory chemistry reviewers
Document structure-based reasoning for flags
More traceable screening rationale
Show 1 more scenario
Toxicology analysts
Prioritize follow-up assays after screening
Reduced test burden
Route compounds with repeated alert patterns to focused experimental planning.
Best for: Fits when teams need transparent alert screening before deeper endpoint modeling.
ACD/Tox Suite
enterprisePredictive toxicity software covering hERG channel blockade, CYP450 inhibition, genotoxicity, and organ-specific toxicity endpoints.
ACD/Tox Suite’s model set combines mutagenicity assays with organ toxicity endpoint predictions in one run.
ACD/Tox Suite is a toxicity prediction software centered on ACD-Labs modeling workflows for regulatory-style endpoints. It supports multiple in silico toxicity endpoints and can handle common chemical structure inputs such as SMILES and SDF for batch prediction runs.
- +Endpoint breadth spanning mutagenicity and organ toxicity predictions
- +Batch-oriented structure processing with SMILES and SDF inputs
- +Clear workflow separation for running multiple endpoint models
- –Automation depends on ACD-specific workflow outputs rather than generic batch APIs
- –Result formats can require reformatting to match internal pipelines
- –Governance controls like RBAC and audit logs are not the primary strength
toxicology analysts
Predict Ames mutagenicity at scale
More consistent endpoint coverage
regulatory submissions teams
Evaluate organ toxicity endpoints
Streamlined review-ready outputs
Show 1 more scenario
lab informatics teams
Standardize batch runs using ACD formats
Fewer formatting conversion steps
Integrations focus on ACD result formats for repeated evaluation and export into existing workflows.
Best for: Fits when teams need repeated in silico toxicity endpoint predictions from SMILES or SDF.
admetSAR
researchWeb-based predictor for ADMET and toxicity properties of chemical compounds.
Curated ADMET toxicity endpoint set tied to Ames mutagenicity and acute toxicity LD50 predictions in one workflow.
admetSAR provides web-based ADMET property prediction for small molecules using curated QSAR models tied to common toxicity endpoints. The tool accepts SMILES input and returns endpoint-level predictions like Ames mutagenicity and acute toxicity LD50 alongside related ADMET readouts.
- +Quick SMILES-to-endpoint predictions for multiple ADMET toxicity categories
- +Endpoint outputs cover widely used assays like Ames and LD50
- +Consistent UI workflow for selecting endpoints and reviewing results
- +Useful for early triage when structural analogs are not yet defined
- –No clearly documented batch prediction API surface for high-throughput pipelines
- –Limited governance controls like RBAC and audit logs for team operations
- –Less support for file-based workflows like SDF or MOL parsing
- –Applicability domain signals and uncertainty handling are not as workflow-ready
medicinal chemists
Estimate Ames mutagenicity from SMILES
Quicker early hazard screening
safety triage teams
Screen acute toxicity LD50
More uniform per-compound outputs
Show 1 more scenario
computational scientists
Compare toxicity endpoints across inputs
Improved internal comparability
Researchers reuse the same web workflow to keep endpoint selection consistent across repeated runs.
Best for: Fits when lab workflows need fast, per-compound toxicity triage from SMILES without pipeline integration.
ADMET Predictor
enterpriseDesktop software for QSAR-based ADMET and toxicity prediction in small-molecule discovery.
Prediction-time applicability filtering that gates results when structures fall outside each model’s reliable domain.
ADMET Predictor by Lmco targets in silico toxicity endpoints using QSAR-style models mapped to common safety assays. It supports small-molecule inputs such as SMILES and SDF parsing and then generates endpoint predictions used for acute and repeated-dose risk triage.
- +Batch predictions across multiple toxicity endpoints in one run
- +SMILES and SDF ingestion supports typical chemoinformatics pipelines
- +Endpoint coverage includes cardio and organ toxicity-style predictions
- +Applicability screening helps avoid extrapolated predictions
- –Automation depth is limited compared with tools that offer full prediction APIs
- –Workflow setup can require chemistry standardization discipline
drug safety analysts
Triage acute and repeated-dose risk
Lower manual triage time
SAR teams
Run cardiotoxicity and hepatotoxicity comparisons
Sharper SAR-linked safety signals
Show 1 more scenario
informatics engineers
Batch parse SDF structures
Faster dataset onboarding
The system supports SDF parsing so teams can process structure sets without manual SMILES entry.
Best for: Fits when teams need batch hazard triage from structure files and accept model applicability limits.
BIOVIA TOPKAT
enterpriseQuantitative structure-toxicity relationship models covering rodent carcinogenicity, mutagenicity, and reproductive toxicity endpoints.
TOPKAT project configurations package model runs into repeatable screening jobs with per-compound applicability guidance.
BIOVIA TOPKAT predicts small-molecule toxicity endpoints from structure inputs and supports batch-style workflows for screening projects. It uses multiple QSAR models for common regulatory-relevant endpoints such as mutagenicity and acute toxicity, and it produces per-compound predicted results tied to applicability guidance.
- +Endpoint coverage tailored to regulatory-style toxicity questions
- +Batch prediction runs support high-throughput structure screening
- +SMILES and SDF ingestion supports common cheminformatics workflows
- +Applicability guidance helps interpret model applicability per compound
- –Model setup and project configuration require disciplined workflow management
- –Export and downstream integration are less direct than API-first tools
- –Some endpoint comparisons require manual interpretation of model outputs
- –Less suited for interactive, iterative modeling without workflow scaffolding
chemistry project managers
Run controlled toxicity screens
More standardized screening runs
toxicity specialists
Predict mutagenicity from structure
More actionable hazard readouts
Show 1 more scenario
medicinal chemistry teams
Batch acute toxicity screening
Higher-throughput hazard triage
Teams run many structures from SMILES or SDF and compare acute toxicity outputs across the set.
Best for: Fits when chemistry teams need repeatable, batch toxicity endpoint predictions from structure files.
Conclusion
After evaluating 9 toxicity prediction software, VEGA stands out as our overall top pick — it scored highest across our combined criteria of features, ease of use, and value, which is why it sits at #1 in the rankings above.
Use the comparison table and detailed reviews above to validate the fit against your own requirements before committing to a tool.
Frequently Asked Questions About Toxicity Prediction Software
How does CASE Ultra handle metabolism-aware toxicity compared with OECD QSAR Toolbox?
Which tool best supports read-across and applicability domain checks inside the same workspace workflow?
What breaks if a workflow needs inspectable rule triggers instead of end-to-end QSAR model outputs?
How do batch throughput workflows differ between VEGA and BIOVIA TOPKAT?
When do structural alert workflows outperform endpoint modeling workflows?
How should a team plan data migration if current outputs are spreadsheets rather than chemistry structure files?
Which approach is better when chemical formats vary across labs, such as SMILES versus SDF exports?
How do admin controls and audit needs affect model-run governance for OECD QSAR Toolbox versus VEGA?
What is the security and access-model tradeoff when a team needs automation via API or integrations?
Tools reviewed
Primary sources checked during evaluation.
Referenced in the comparison table and product reviews above.
How to Choose the Right Toxicity Prediction Software
We separate options by how they turn your chemical inputs into trustworthy toxicity outputs—especially under dataset shift, missing values, and time-to-results. Look first at interpretability and uncertainty, then at automation and API fit for your workflow.
Uncertainty and explanation for predictions
Why it matters
When you see toxicity predictions, you also need uncertainty and a readable rationale so you can prioritize follow-up and catch questionable calls. This matters more than raw accuracy because decisions often hinge on borderline compounds.
How to check
Run the same input across the tool and check whether it reports uncertainty or confidence bands alongside the predicted endpoint. Ask for a per-compound explanation and verify it’s consistent with what the UI or docs claim.
Flexible chemical input handling
Why it matters
Toxicity prediction workflows break when your molecules can’t be ingested cleanly or when preprocessing changes outcomes. Input flexibility reduces silent errors and rework.
How to check
Prepare a small batch in the most common format you already use and try importing it with salts/mixtures you actually have. Confirm how the tool represents multi-component structures and whether it flags invalid or ambiguous entries.
Applicability controls for out-of-domain compounds
Why it matters
A model that works only on its training chemistry can mislead you on new scaffolds. Applicability controls help you detect when predictions may be unreliable.
How to check
In a demo, ask for a mechanism that marks out-of-domain or low-support inputs. Then submit a diverse set and check whether the tool tags or down-weights those cases.
Batch workflow and output traceability
Why it matters
Toxicity prediction projects often move from prototypes to larger runs. Batch support with traceable outputs makes results reviewable and reproducible.
How to check
Submit a batch and confirm you can export structured results with per-input identifiers and a run ID. Check whether outputs include versioning fields you can cite in internal reports.
API and automation for prediction runs
Why it matters
When you need repeatable toxicity predictions, API and automation determine whether the tool fits daily workflows. A strong automation surface reduces manual transcription errors.
How to check
Request an API-based run using a test dataset and review the request/response fields for endpoint selection and identifiers. Confirm you can script end-to-end runs and retrieve results programmatically.
Red flags
- Predictions without uncertainty or a clear explanation trail
- Silent failures on invalid or ambiguous chemical structures
- No way to detect out-of-domain inputs before trusting outputs
Fit by situation
- If you need decision-ready outputs for borderline compounds, prioritize Uncertainty and explanation for predictions.
- If your team regularly mixes real-world molecules with salts or mixtures, prioritize Flexible chemical input handling.
- If you must run repeatable predictions from pipelines, prioritize API and automation for prediction runs.
Funding and competing interests
This study was co-funded by several of the vendors assessed in it. No single vendor funded it. Funders could propose the market studied.
They had no role in selecting vendors, setting or weighting criteria, analysing data or drawing conclusions, and they received the same factual-accuracy check as every other vendor assessed.
Market definition, inclusion rules and criteria weights were fixed by an editor before research began and did not change afterwards. Editorial process →
Keep exploring
Comparing two specific tools?
Software Alternatives
See head-to-head software comparisons with feature breakdowns, pricing, and our recommendation for each use case.
Explore software alternatives→Need a personal recommendation?
Software Advisory Service
Skip months of vendor evaluation. Our analysts recommend the right tool for your business in 2–4 weeks.
Talk to an analyst →